Gary R. Lichtenstein

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +5

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.8K citations · Full text

ACG Clinical Guideline: Management of Crohn's Disease in Adults

Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs et al. · The American Journal of Gastroenterology · 2018 · 1.4K citations

Functional Gastrointestinal Disorder, Gastroenterology, Practice Parameters Committee +7

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

Paul Rutgeerts, Brian G. Feagan, Gary R. Lichtenstein et al. · Gastroenterology · 2004 · 947 citations

Inflammation, Episodic Treatment Strategies, Anti-inflammatory +4

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean‐Frédéric Colombel, Paul Rutgeerts, Walter Reinisch et al. · Gastroenterology · 2011 · 909 citations · Full text

Inflammation, Mucosal Healing, Anti-inflammatory +10